Symbol
Fate Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$0.77
Current price of the stock
$4M
Trading volume of the stock
$90.7M
Market capitalization of the company
Micro Cap
Category of market capitalization
29.69%
Long-term growth mean estimate
3.71
Mean analyst rating
734.16%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
8.29
Current ratio
100.00%
Gross profit margin
-1703.87%
Operating profit margin
-1703.87%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-1551.01%
Pretax profit margin
-1551.01%
Net profit margin
-13.16%
Measures profitability relative to shareholders' equity
-13.16%
ROE excluding intangible assets
-9.63%
Measures profitability relative to total assets
-13.16%
Measures profitability relative to invested capital
0.01
Asset turnover ratio
-
Inventory turnover ratio
0.74
Receivables turnover ratio
120.83
Average number of days it takes to collect receivables
-0.47
Measures valuation relative to earnings
-0.46
P/E based on future earnings estimates
6.74
Measures valuation relative to sales
0.24
Measures valuation relative to book value
-0.25
Measures valuation relative to operating cash flow
-0.25
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
